Prognostic Value of Changes in Preoperative and Postoperative Serum CA19-9 Levels in Gastric Cancer

Abstract

Objective: The prognostic significance of serum CA19-9 levels in gastric cancer patients remains a matter debate. The aim of this study was to determine the prognostic value of changes in preoperative and postoperative serum CA19-9 levels in patients with gastric cancer. Methods: A total of 1,046 gastric cancer patients who underwent curative gastrectomy in West China Hospital of Sichuan University from January 2011 to December 2016 were analyzed retrospectively. Patients were categorized by minimum P-value using X-tile, while the baseline confounders for CA19-9 changes were balanced through propensity score matching (PSM). The relationships between CA19-9 changes and other clinicopathologic features were measured. Univariate and multivariate analysis were performed to explore the risk factors associated with survival outcomes. Results: We included 653 patients. Changes in CA19-9 levels significantly correlated with age, tumor size, macroscopic type, histological grade, T stage and TNM stage. Kaplan-Meier curves revealed that patients with CA19-9 changes <20% had significant better overall survival than those with changes more than 20% (p < 0.001); Cox regression analysis revealed the CA19-9 change (p = 0.010), gender (p = 0.031), histological grade (p = 0.036) and TNM stage (p < 0.001) were independent risk factors for survival after PSM. Stratification analysis indicated that patients with CA19-9 change more than 20% had worse prognosis that those with CA19-9 change no more than 20% in male (p = 0.002), poorly differentiated or undifferentiated type (p = 0.031) and TNM stage III (p = 0.006). Conclusion: Changes in preoperative and postoperative serum CA19-9 levels were closely associated with clinicopathological traits and was an independent prognostic factor in gastric cancer patients. This parameter may be a reliable marker for prediction of survival.

Early Study of Tumor Abnormal Protein in Gastric Adenocarcinoma

“…The change in serum CA199 levels before and after surgery has been confirmed to be an independent prognostic factor for gastric cancer patients. 20 However, when we conducted data statistics, we found that most of the patients’ tumor markers were within the normal range and not higher than the normal value. The size of tumor tissue, blood supply, differentiation of tumor cells, and tumor stage all affect the concentration of tumor markers to varying degrees.…”

Low Pretreatment Albumin-to-Globulin Ratio Predicts Poor Prognosis in Gastric Cancer: Insight From a Meta-Analysis

“…However, patients with similar pathological features often presented diverse survival outcomes. Although the prognostic significance of certain inflammatory markers ( 2 , 3 ) and tumor markers ( 4 , 5 ) in GC have already been certified, we need to identify more prognostic markers that are inexpensive to test and easily available before treatment for enabling precision prediction.…”

CT radiomics for predicting PD-L1 expression on tumor cells in gastric cancer

“…Serum tumor markers, indirectly indicating tumor burden, are commonly used for malignant tumor diagnosis, e cacy evaluation, and prognosis [22][23][24]. Lang D et al demonstrated that the early change of serum tumor markers is predictive of progression-free and overall survival in patients with NSCLC treated by PD-1 targeted therapy [25].…”